Hyperandrogenic Oligomenorrhea and Metabolic Risks Across Menopausal Transition.

CONCLUSIONS: Longitudinal evidence suggests that a history of androgen excess and menstrual irregularity is not associated with worsening of metabolic health after menopause. Our findings challenge the notion that a history of concurrent HA and Oligo reflects ongoing cardiometabolic risk in postmenopausal women.
PMID: 24517154 [PubMed - as supplied by publisher]

Source: The Journal of Clinical Endocrinology and Metabolism - February 11, 2014 Category: Endocrinology Authors: Polotsky AJ, Allshouse AA, Crawford SL, Harlow SD, Khalil N, Kazlauskaite R, Santoro N, Legro RS Tags: J Clin Endocrinol Metab Source Type: research